Alnylam Pharmaceuticals
ALNY
#555
Rank
โ‚ฌ38.26 B
Marketcap
288,50ย โ‚ฌ
Share price
2.01%
Change (1 day)
20.01%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company